M

Marinus Pharmaceuticals
D

MRNS

0.54470
USD
0.00
(0.68%)
مغلق
حجم التداول
22,321
الربح لكل سهم
-0
العائد الربحي
-
P/E
-0
حجم السوق
30,077,509
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACAD
    -0.085
    (-0.48%)
    17.805 USD
    ALNY
    ALNY
    1.73
    (0.65%)
    266.69 USD
    B
    BPMC
    -0.940
    (-0.84%)
    111.190 USD
    I
    INSM
    1.685
    (2.20%)
    78.450 USD
    K
    KPTI
    -0.01090
    (-1.60%)
    0.67170 USD
    P
    PTCT
    -0.150
    (-0.33%)
    45.100 USD
    S
    SAGE
    0.07500
    (1.08%)
    7.02500 USD
    المزيد
الأخبار
المقالات

العنوان: Marinus Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.